… However, to date, such ideal biomarkers of heart disease have yet to be identified, despite …
a candidate molecular heart disease biomarker, galectin-3 (Gal-3). Galectins are composed of …

… Galectins have a key role as modulators of cell surface functions and signaling in a wide range
of inflammatory diseases … coronary heart disease (CHD) on salivary and serum Galectin-3 …

… Hence, Gal-3 has been found to be an individual predictor of acute and chronic heart failure
… In congenital heart disease (CHD), Gal-3 correlates with cardiac mortality and complications …

… In this study, we evaluated the prognostic value of plasma galectin-3 levels in patients with
coronary heart disease (CHD) and chronic heart failure (HF) and selected 261 CHD patients …

… Compared with the control group, Galectin 3 levels in patients with coronary heart disease …
; Compared with SAP group, a rise in Galectin 3 levels were observed in patients with UAP or …

… heart disease, including hypertension, HF and cardiomyopathy.3, 4 Galectin-3, a member of
the galectin … Indeed, accumulating evidence has shown that galectin-3 mediates myocardial …

… This study presents novel, important data regarding circulating Gal-3 in ischemic heart
disease. There was no relationship between Gal-3 levels and acute myocardial ischemic injury, a …

… patients with heart failure. This study aims to investigate the release of galectin-3 and its
association with cardiovascular events in patients with adult congenital heart disease (ACHD). …

… Galectin-3 plays a prominent role in chronic inflammation and has been implicated in the
development of many disease conditions, including heart disease. Galectin-3, a regulatory …

… for heart failure and cardiovascular disease (CVD). However, it remains unclear whether
galectin-3 … heart disease (CHD) after adjustment for multiple established and novel risk factors. …